Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FALSE! All numbered items from 1 to 7 come from the mouth of "Eich"!
(And... Here's the antidote to "Eich"s "Truth"!)
The first paragraph is excerpted from the 10K, that's true, but as anybody who's ever read one of these documents can tell you that it's standard legalese boilerplate. In fact it's a miracle that Pluristem only "accumulated a deficit of $215,697,000" in over a decade of operation, with NO debt at all, and having accomplished miracles in terms of their science and and presence in the clinic for multiple indications, with many more in the pipeline.
REPEAT: All the following comes from the mouth of "Eichking"! Lets go thru and respond to each. This is a worthwhile exercise since this sort of "analysis" is a constant theme (you'll see it repeated EVERY day!)
1) The DoD hasn't even started trials, and may not EVER. PSTI is "interested" in further discussions on this with them. LOL
A totally deceptive claim! This a reference to R18 and the DoD has been gathering data for years. Given the nature of ARS, the only way to test is with non-human subjects (nobody will volunteer to receive a fatal dose of radiation). The DoD is getting the kind of data that will be sufficient for "approval" in the form of a procurement and acquisition for stockpiling. Could happen anytime (maybe tomorrow AM, or a few months, we'll see).
2) If their products were so miraculous, ONE patient would have come forward with their life saving story
Misleading! We have had numerous reports from doctors working with PAD patients: all very positive and with strong commitment to pursue the objective of mitigating the debilitating effects of the disease. The most knowledgeable people are "coming forward"! Patient testimonials come later!
3) If their products were so miraculous, the PPS would not be $1.33 PATHETIC
More of the "market" is talking nonsense!
4) They will dilute again, soon, taking this under $1, never to return again until the next RS, bank on it
NO, NO, NO, Don't "bank on it"! It's a totally unfounded opinion! Very pessimistic! You need to be rationally optimistic to do ANY investing, and look at the success Pluristem has had in getting funds with minimal dilution (of course, there will be SOME dilution, no cause for panic, or even distress, it's normal!!!! )
5) More than half of the 10-K was dedicated to how they pay the leeches in management.
Standard anti management rhetoric. They take a much bigger risk than the posters here, and deserve proper compensation. Having seen these type of folks close up, I know the kind of intelligence and dedication and hard work required to guide a company like Pluristem to success. Totally in line with other late stage biotechs.
The quote "Eich" gives us: "they don't know when they will be profitable....."IF EVER" LMAO." is particularly deceptive, given that it's standard in EVERY safe harbor section of EVERY 10K and similar corporate documents (without the "LMAO", the version of the document that I read does NOT have that, perhaps "Eich" has access to the original)
6) The fact so much of the 10K is dedicated to employee compensation and so little dedicated to the actual science speaks volumes.
Just a rehash of point 5! I don't think it speaks "volumes", I don't think it even squeaks a scintilla!
7) This was nothing but a rehash of what they have already said, which is nothing but spin.
It's actually a legally required document, it's MOSTLY legalese, and boilerplate (as expected, it's NORMAL!). They do talk about the science in the 10-K and a multitude of other sources, no shortage of science information. You just have to look.
Quote: Need I go on? Not really! These points have been made MANY, MANY times before!
Quote: DEAD MONEY is an understatement. Not by the normal definition of "understatement". I would characterize it as a FALSE statement.
FALSE! All numbered items from 1 to 7 come from the mouth of "Eich"!
(And... Here's the antidote to "Eich"s "Truth"!)
The first paragraph is excerpted from the 10K, that's true, but as anybody who's ever read one of these documents can tell you that it's standard legalese boilerplate. In fact it's a miracle that Pluristem only "accumulated a deficit of $215,697,000" in over a decade of operation, with NO debt at all, and having accomplished miracles in terms of their science and and presence in the clinic for multiple indications, with many more in the pipeline.
REPEAT: All the following comes from the mouth of "Eichking"! Lets go thru and respond to each. This is a worthwhile exercise since this sort of "analysis" is a constant theme (you'll see it repeated EVERY day!)
1) The DoD hasn't even started trials, and may not EVER. PSTI is "interested" in further discussions on this with them. LOL
A totally deceptive claim! This a reference to R18 and the DoD has been gathering data for years. Given the nature of ARS, the only way to test is with non-human subjects (nobody will volunteer to receive a fatal dose of radiation). The DoD is getting the kind of data that will be sufficient for "approval" in the form of a procurement and acquisition for stockpiling. Could happen anytime (maybe tomorrow AM, or a few months, we'll see).
2) If their products were so miraculous, ONE patient would have come forward with their life saving story
Misleading! We have had numerous reports from doctors working with PAD patients: all very positive and with strong commitment to pursue the objective of mitigating the debilitating effects of the disease. The most knowledgeable people are "coming forward"! Patient testimonials come later!
3) If their products were so miraculous, the PPS would not be $1.33 PATHETIC
More of the "market" is talking nonsense!
4) They will dilute again, soon, taking this under $1, never to return again until the next RS, bank on it
NO, NO, NO, Don't "bank on it"! It's a totally unfounded opinion! Very pessimistic! You need to be rationally optimistic to do ANY investing, and look at the success Pluristem has had in getting funds with minimal dilution (of course, there will be SOME dilution, no cause for panic, or even distress, it's normal!!!! )
5) More than half of the 10-K was dedicated to how they pay the leeches in management.
Standard anti management rhetoric. They take a much bigger risk than the posters here, and deserve proper compensation. Having seen these type of folks close up, I know the kind of intelligence and dedication and hard work required to guide a company like Pluristem to success. Totally in line with other late stage biotechs.
The quote "Eich" gives us: "they don't know when they will be profitable....."IF EVER" LMAO." is particularly deceptive, given that it's standard in EVERY safe harbor section of EVERY 10K and similar corporate documents (without the "LMAO", the version of the document that I read does NOT have that, perhaps "Eich" has access to the original)
6) The fact so much of the 10K is dedicated to employee compensation and so little dedicated to the actual science speaks volumes.
Just a rehash of point 5! I don't think it speaks "volumes", I don't think it even squeaks a scintilla!
7) This was nothing but a rehash of what they have already said, which is nothing but spin.
It's actually a legally required document, it's MOSTLY legalese, and boilerplate (as expected, it's NORMAL!). They do talk about the science in the 10-K and a multitude of other sources, no shortage of science information. You just have to look.
Quote: Need I go on? Not really! These points have been made MANY, MANY times before!
Quote: DEAD MONEY is an understatement. Not by the normal definition of "understatement". I would characterize it as a FALSE statement.
Then late next spring, the new dilution will occur. ... [RS] probably close to 100% by January 2020.
Any chance something positive occurring in the 15 months? Good data from first NEO patients, progress on HOT and maybe an "accretive" deal, perhaps some milestones from Amgen...? I think an RS is substantially less than 100%!
We need more data to be more optimistic.. Actually the data is good untill now. Sometimes is very good. We don't have problems with safety in our new fantastic product PLX-R18.
Sometimes "good" to "very good" makes me optimistic. I also look forward to more data, but given what we've seen so far, I think the chances of a continuing stream of good news is most likely. Nevertheless, I'd like to have it in the public record as soon as possible.
We all got the Christmas gift in advance. Now a New Year Gift to remember ?
Don't worry! It's just a guess! A guess from someone who's guesses are always very pessimistic. I personally discount these sort of "guesses". For a balanced perspective reread hovacare's last five or ten posts.
Well when you and the sage continue to provide unbalanced information ( much of which is non-factual and misleading ), done only to serve your own narratives, Ill cease my curt retorts.
Once you decide to invest, the "balance" has clearly tipped in one direction. The rationale for investing is a combination of "factual", that is data, and extrapolation from the data, that's interpretation, not factual, and the value and validity depends on your interpretive skills.
Ill cease my curt retorts.
Please don't! "Curt retorts" are much better than long, laborious, long-winded, incoherent, verbose retorts. I like them.
only to serve your own narratives
Almost correct, just substitute "conviction" for "narrative".
Eventually it WILL happen! Nobody is standing still, the clinical trials are going at full speed, corporate wheeling and dealing is happening, consultations are going on, patents are being submitted, academic collaborators are using Pluristem's MSCs in their work...etc.
Something will happen!!! (I expect it's going to be good!).
Volume picking up on the downside. Not a good sign.
Wouldn't worry too much! Last week we had "good signs", ... it does change from day to day. The ongoing clinical trials do not change at the drop of a hat, they will determine the ultimate outcome. Why worry about "signs" when data is on its way?
It does not! Sort of like listening to Beethoven's Ninth, and filtering out everything but the kettle drums. You'll have an altogether different "musical" experience.
There are facts and there are opinions! There are reasonable opinions, and there are assertion that are absolutist, and clearly unsupportable, raja's latest is in the latter category.
Here's a counter opinion: It is NOT beyond Ken to repair the damage!
That was easy, and contains at least equal rhetorical power. I also assert that my (counter)assertion is much more plausible, and on a more solid footing! I can't tell from a textual analysis of raja's post whether he means that "Ken" doesn't have what it takes, or the company is beyond saving, no matter who the CEO happens to be (I guess it doesn't really matter).
Low institutional ownership (like 25%) is negative for a company that has been in business as long as Aurinia. Everyone knows the story by now....
Exactly! So... what can we glean from the purported "low institutional ownership"? What secret information is there, that is not known to anyone, except "intitutions"? I think the real story is in the clinic and the only way to prognosticate is to look at data available to date, and that looks pretty solid!
FALSE! All numbered items from 1 to 7 come from the mouth of "Eich"!
The first paragraph is excerpted from the 10K! True, but as anybody who's ever read one of these documents can tell you that it's standard legalese boilerplate. In fact it's a miracle that Pluristem only "accumulated a deficit of $215,697,000" in over a decade of operation, with NO debt at all, and having accomplished miracles in terms of their science and and presence in the clinic for multiple indications, with many more in the pipeline.
REPEAT: All the following comes from the mouth of "Eichking"! Lets go thru and respond to each. This is a worthwhile exercise since this sort of "analysis" is a constant theme (you'll see it repeated EVERY day!)
1) The DoD hasn't even started trials, and may not EVER. PSTI is "interested" in further discussions on this with them. LOL
A totally deceptive claim! This a reference to R18 and the DoD has been gathering data for years. Given the nature of ARS, the only way to test is with non-human subjects (nobody will volunteer to receive a fatal dose of radiation). The DoD is getting the kind of data that will be sufficient for "approval" in the form of a procurement and acquisition for stockpiling. Could happen anytime (maybe tomorrow AM, or a few months, we'll see).
2) If their products were so miraculous, ONE patient would have come forward with their life saving story
Misleading! We have had numerous reports from doctors working with PAD patients: all very positive and with strong commitment to pursue the objective of mitigating the debilitating effects of the disease. The most knowledgeable people are "coming forward"! Patient testimonials come later!
3) If their products were so miraculous, the PPS would not be $1.33 PATHETIC
More of the "market" is talking nonsense!
4) They will dilute again, soon, taking this under $1, never to return again until the next RS, bank on it
NO, NO, NO, Don't "bank on it"! It's a totally unfounded opinion! Very pessimistic! You need to be rationally optimistic to do ANY investing, and look at the success Pluristem has had in getting funds with minimal dilution (of course, there will be SOME dilution, no cause for panic, or even distress, it's normal!!!! )
5) More than half of the 10-K was dedicated to how they pay the leeches in management.
Standard anti management rhetoric. They take a much bigger risk than the posters here, and deserve proper compensation. Having seen these type of folks close up, I know the kind of intelligence and dedication and hard work required to guide a company like Pluristem to success. Totally in line with other late stage biotechs.
The quote "Eich" gives us: "they don't know when they will be profitable....."IF EVER" LMAO." is particularly deceptive, given that it's standard in EVERY safe harbor section of EVERY 10K and similar corporate documents (without the "LMAO", the version of the document that I read does NOT have that, perhaps "Eich" has access to the original)
6) The fact so much of the 10K is dedicated to employee compensation and so little dedicated to the actual science speaks volumes.
Just a rehash of point 5! I don't think it speaks "volumes", I don't think it even squeaks a scintilla!
7) This was nothing but a rehash of what they have already said, which is nothing but spin.
It's actually a legally required document, it's MOSTLY legalese, and boilerplate (as expected, it's NORMAL!). They do talk about the science in the 10-K and a multitude of other sources, no shortage of science information. You just have to look.
Quote: Need I go on? Not really! These points have been made MANY, MANY times before!
Quote: DEAD MONEY is an understatement. Not by the normal definition of "understatement". I would characterize it as a FALSE statement.
(And... Here's the antidote to "Eich"s "Truth"!) This is what happens when you don't pay for bandwidth! LOL!
FALSE! All numbered items from 1 to 7 come from the mouth of "Eich"!
The first paragraph is excerpted from the 10K! True, but as anybody who's ever read one of these documents can tell you that it's standard legalese boilerplate. In fact it's a miracle that Pluristem only "accumulated a deficit of $215,697,000" in over a decade of operation, with NO debt at all, and having accomplished miracles in terms of their science and and presence in the clinic for multiple indications, with many more in the pipeline.
REPEAT: All the following comes from the mouth of "Eichking"! Lets go thru and respond to each. This is a worthwhile exercise since this sort of "analysis" is a constant theme (you'll see it repeated EVERY day!)
1) The DoD hasn't even started trials, and may not EVER. PSTI is "interested" in further discussions on this with them. LOL
A totally deceptive claim! This a reference to R18 and the DoD has been gathering data for years. Given the nature of ARS, the only way to test is with non-human subjects (nobody will volunteer to receive a fatal dose of radiation). The DoD is getting the kind of data that will be sufficient for "approval" in the form of a procurement and acquisition for stockpiling. Could happen anytime (maybe tomorrow AM, or a few months, we'll see).
2) If their products were so miraculous, ONE patient would have come forward with their life saving story
Misleading! We have had numerous reports from doctors working with PAD patients: all very positive and with strong commitment to pursue the objective of mitigating the debilitating effects of the disease. The most knowledgeable people are "coming forward"! Patient testimonials come later!
3) If their products were so miraculous, the PPS would not be $1.33 PATHETIC
More of the "market" is talking nonsense!
4) They will dilute again, soon, taking this under $1, never to return again until the next RS, bank on it
NO, NO, NO, Don't "bank on it"! It's a totally unfounded opinion! Very pessimistic! You need to be rationally optimistic to do ANY investing, and look at the success Pluristem has had in getting funds with minimal dilution (of course, there will be SOME dilution, no cause for panic, or even distress, it's normal!!!! )
5) More than half of the 10-K was dedicated to how they pay the leeches in management.
Standard anti management rhetoric. They take a much bigger risk than the posters here, and deserve proper compensation. Having seen these type of folks close up, I know the kind of intelligence and dedication and hard work required to guide a company like Pluristem to success. Totally in line with other late stage biotechs.
The quote "Eich" gives us: "they don't know when they will be profitable....."IF EVER" LMAO." is particularly deceptive, given that it's standard in EVERY safe harbor section of EVERY 10K and similar corporate documents (without the "LMAO", the version of the document that I read does NOT have that, perhaps "Eich" has access to the original)
6) The fact so much of the 10K is dedicated to employee compensation and so little dedicated to the actual science speaks volumes.
Just a rehash of point 5! I don't think it speaks "volumes", I don't think it even squeaks a scintilla!
7) This was nothing but a rehash of what they have already said, which is nothing but spin.
It's actually a legally required document, it's MOSTLY legalese, and boilerplate (as expected, it's NORMAL!). They do talk about the science in the 10-K and a multitude of other sources, no shortage of science information. You just have to look.
Quote: Need I go on? Not really! These points have been made MANY, MANY times before!
Quote: DEAD MONEY is an understatement. Not by the normal definition of "understatement". I would characterize it as a FALSE statement.
4 of them have the BUY rec. If it were 1 or 2 I'd be more cautious. So I must assume they are aware of the fundamentals and the financials and have looked over the 10K. So I guardedly respect their call.
They are recommending "BUY"! That's the "extreme" side that I'm on. In fact they're more extreme than I am, I don't recommend anything, I just state MY reasons for getting into Pluristem and debunk what I consider false, dishonest and misleading posts. To paraphrase Goldwater:
Moderation in the protection of Pluristem is no virtue; extremism in the defense of ROI is no vice.
It's very important because we need to calibrate the exact degree of the DEADNESS (although, normally it's a binary condition, you usually cannot be a little bit dead, or 98 percent dead and I would like to know HOW dead my MONEY is. That way I can use some sort of tool to measure significant DEADNESS movements in either direction, ... WAIT!!, I just had a great idea, I'll look to hopester's chart report, we'll call it the "DEADNESS" report)
One,two punch from "Eich":
Post 1:
Need I go on? DEAD MONEY is an understatement.
Post 2 (a bit later):
.this PIG of a stock has NEVER provided any such foresight. PATHETIC DEAD MONEY GONNA DILUTE THEN RS PSTI
Are we approaching the next level yet? Are we still in "understatement" category?
I'm very curious when we get beyond "understatement", is it going to be understatement plus, or very understated understatement, barely understated or maybe overstated understatement, understated overstatement, or ... well, the possibilities are endless, I'm anticipating!
FALSE! All numbered items from 1 to 7 come from the mouth of "Eich"!
The first paragraph is excerpted from the 10K! True, but as anybody who's ever read one of these documents can tell you that it's standard legalese boilerplate. In fact it's a miracle that Pluristem only "accumulated a deficit of $215,697,000" in over a decade of operation, with NO debt at all, and having accomplished miracles in terms of their science and and presence in the clinic for multiple indications, with many more in the pipeline.
REPEAT: All the following comes from the mouth of "Eichking"! Lets go thru and respond to each. This is a worthwhile exercise since this sort of "analysis" is a constant theme (you'll see it repeated EVERY day!)
1) The DoD hasn't even started trials, and may not EVER. PSTI is "interested" in further discussions on this with them. LOL
A totally deceptive claim! This a reference to R18 and the DoD has been gathering data for years. Given the nature of ARS, the only way to test is with non-human subjects (nobody will volunteer to receive a fatal dose of radiation). The DoD is getting the kind of data that will be sufficient for "approval" in the form of a procurement and acquisition for stockpiling. Could happen anytime (maybe tomorrow AM, or a few months, we'll see).
2) If their products were so miraculous, ONE patient would have come forward with their life saving story
Misleading! We have had numerous reports from doctors working with PAD patients: all very positive and with strong commitment to pursue the objective of mitigating the debilitating effects of the disease. The most knowledgeable people are "coming forward"! Patient testimonials come later!
3) If their products were so miraculous, the PPS would not be $1.33 PATHETIC
More of the "market" is talking nonsense!
4) They will dilute again, soon, taking this under $1, never to return again until the next RS, bank on it
NO, NO, NO, Don't "bank on it"! It's a totally unfounded opinion! Very pessimistic! You need to be rationally optimistic to do ANY investing, and look at the success Pluristem has had in getting funds with minimal dilution (of course, there will be SOME dilution, no cause for panic, or even distress, it's normal!!!! )
5) More than half of the 10-K was dedicated to how they pay the leeches in management.
Standard anti management rhetoric. They take a much bigger risk than the posters here, and deserve proper compensation. Having seen these type of folks close up, I know the kind of intelligence and dedication and hard work required to guide a company like Pluristem to success. Totally in line with other late stage biotechs.
The quote "Eich" gives us: "they don't know when they will be profitable....."IF EVER" LMAO." is particularly deceptive, given that it's standard in EVERY safe harbor section of EVERY 10K and similar corporate documents (without the "LMAO", the version of the document that I read does NOT have that, perhaps "Eich" has access to the original)
6) The fact so much of the 10K is dedicated to employee compensation and so little dedicated to the actual science speaks volumes.
Just a rehash of point 5! I don't think it speaks "volumes", I don't think it even squeaks a scintilla!
7) This was nothing but a rehash of what they have already said, which is nothing but spin.
It's actually a legally required document, it's MOSTLY legalese, and boilerplate (as expected, it's NORMAL!). They do talk about the science in the 10-K and a multitude of other sources, no shortage of science information. You just have to look.
Quote: Need I go on? Not really! These points have been made MANY, MANY times before!
Quote: DEAD MONEY is an understatement. Not by the normal definition of "understatement". I would characterize it as a FALSE statement.
FALSE! All numbered items from 1 to 7 come from the mouth of "Eich"!
The first paragraph is excerpted from the 10K! True, but as anybody who's ever read one of these documents can tell you that it's standard legalese boilerplate. In fact it's a miracle that Pluristem only "accumulated a deficit of $215,697,000" in over a decade of operation, with NO debt at all, and having accomplished miracles in terms of their science and presence in the clinic for multiple indications, with many more in the pipeline.
REPEAT: All the following comes from the mouth of "Eichking"! Lets go thru and respond to each. This is a worthwhile exercise since this sort of "analysis" is a constant theme (you'll see it repeated EVERY day!)
1) The DoD hasn't even started trials, and may not EVER. PSTI is "interested" in further discussions on this with them. LOL
A totally deceptive claim! This a reference to R18 and the DoD has been gathering data for years. Given the nature of ARS, the only way to test is with non-human subjects (nobody will volunteer to receive a fatal dose of radiation). The DoD is getting the kind of data that will be sufficient for "approval" in the form of a procurement and acquisition for stockpiling. Could happen anytime (maybe tomorrow AM, or a few months, we'll see).
2) If their products were so miraculous, ONE patient would have come forward with their life saving story
Misleading! We have had numerous reports from doctors working with PAD patients: all very positive and with strong commitment to pursue the objective of mitigating the debilitating effects of the disease. The most knowledgeable people are "coming forward"! Patient testimonials come later!
3) If their products were so miraculous, the PPS would not be $1.33 PATHETIC
More of the "market" is talking nonsense!
4) They will dilute again, soon, taking this under $1, never to return again until the next RS, bank on it
NO, NO, NO, Don't "bank on it"! It's a totally unfounded opinion! Very pessimistic! You need to be rationally optimistic to do ANY investing, and look at the success Pluristem has had in getting funds with minimal dilution (of course, there will be SOME dilution, no cause for panic, or even distress, it's normal!!!! )
5) More than half of the 10-K was dedicated to how they pay the leeches in management.
Standard anti management rhetoric. They take a much bigger risk than the posters here, and deserve proper compensation. Having seen these type of folks close up, I know the kind of intelligence and dedication and hard work required to guide a company like Pluristem to success. Totally in line with other late stage biotechs.
The quote "Eich" gives us: "they don't know when they will be profitable....."IF EVER" LMAO." is particularly deceptive, given that it's standard in EVERY safe harbor section of EVERY 10K and similar corporate documents (without the "LMAO", the version of the document that I read does have that, perhaps "Eich" has access to the original)
6) The fact so much of the 10K is dedicated to employee compensation and so little dedicated to the actual science speaks volumes.
Just a rehash of point 5! I don't think it speaks "volumes", I don't think it even squeaks a scintilla! 7) This was nothing but a rehash of what they have already said, which is nothing but spin.
It's actually a legally required document, it's MOSTLY legalese, and boilerplate (as expected, it's NORMAL!). They do talk about the science in the 10-K and a multitude of other sources, no shortage of science information. You just have to look.
Need I go on?
Not really! These points have been made MANY, MANY times before!
DEAD MONEY is an understatement.
Not by the normal definition of "understatement". I would characterize it as a FALSE statement.
LOL! No it's not! It's a WONDERFUL, BRILLIANT company with massive POTENTIAL and ... it's ALIVE, ALIVE, it's VIBRANT, with talented scientists working tirelessly, and will it take the medical world by storm and make all investors who refuse to take your "advise" very rich!!
As a general rule, what the market tells you is to buy high and sell low. That's usually the wrong thing to do.
That is indeed my statement, and I stand by it.
The only thing the market tells you is the PPS now. MOST stocks that are high now, were at one time much lower. What is interesting is how many times a day you see the same platitude about the "market" telling you whatever. That's why boiler room hacks and recreational trolls don't need much creativity!
Could you cut this garbage? Hopester might think you're being "extreme". I just think you're revealing who and what your are! That is definitely not in your interest!
The information below is public knowledge and makes the point that there's a good chance that based on the two placenta regimen the results could be quite spectacular.
1. those who got two doses of 300 million cells, with each dose originating from a different placenta, had no revascularization procedures during follow up. 2. This is indeed a very positive finding and suggests that with this dosing regimen we could seriously reduce the need for revasc. procedures.
from Bloomberg article (2018.09.10):
A clinical study of a pioneering placenta-based cell therapy product, PLX-PAD, has shown that it can dramatically enhance the mobility of patients with peripheral arterial disease (PAD) in their legs, and greatly reduce, or even eliminate, their need for surgery and hospitalization.
Not an understatement, a call for action for those who buy your "analysis", specifically SELL NOW!!!!. As for me, I don't find anything from this poster particularly persuasive, in fact I've been buying more, on top of a pretty good stake even now.
Here is TRUTH....from their own mouths (10K):
There is good information there, but much of it is standard boilerplate legalese. Only very naive investors will take it (or "Eich"s "interpretation" of it) seriously. It's lawyerly mendacity at its finest (or ugliest).
The paper on sepsis is very interesting. One more indication of the enormous potential of Pluristem's technology, and certainly raises the obvious question of when some BP tries to acquire us (assuming that's what management wants). My preference is to partner some indication so that the enormous therapeutic benefits are brought to the clinic as fast as possible, but Pluristem can fully develop and market some indications such as CLI and ARS. Just on those two alone, Pluristem will be a massive investment success. Thanks for the link!!
Very interesting! Long term storage and successful reconstitution of cells looks really good. We don't need 20 years plus for PLX cells, but the longevity of CBU should give everyone confidence about viability and long shelf life.
Published stability data are available for cord blood units (CBU) stored for up to 23.5 years, showing satisfactory recovery of nucleated cells and colony-forming units (CFU) after long-term storage.
News 
Market Data 
Discover 
AI
